This profile is built from public research funding records (CIHR, NSERC and SSHRC). We have not imported them from a University of Ottawa directory, so their publications, courses and email address may be missing. Find their university profile.
Research
Latest funding
- $937,125
Bi-locus gene replacement for enhancing permanent correction of genetic airway diseases
CIHR · 2021 · Co-investigator
- $940,950
Targeting airway cells for gene-editing to correct genetic diseases
CIHR · 2018 · Co-investigator
- $149,966
Sex differences in arginine function in experimental and human bronchopulmonary dysplasia
CIHR · 2017 · Principal investigator
Bi-locus gene replacement for enhancing permanent correction of genetic airway diseases
Principal investigators: Hu, Jim
Keywords: Airway Diseases; Cystic Fibrosis; Gene Therapy
Targeting airway cells for gene-editing to correct genetic diseases
Principal investigators: Hu, Jim
Keywords: Airway Diseases; Cystic Fibrosis; Gene Delivery
Sex differences in arginine function in experimental and human bronchopulmonary dysplasia
Principal investigators: Jankov, Robert P; Grasemann, Hartmut
Keywords: Arginase; Bronchopulmonary Dysplasia; Chronic Lung Injury; Lung Mechanics; Morphometry; Nitric Oxide; Prematurity; Pulmonary Hypertension; Stereology
CIHR Emerging Team in Cystic Fibrosis Therapy
Principal investigators: Ratjen, Felix; Bear, Christine E; Durie, Peter R; Ellis, James R; Rotin, Daniela
Keywords: Clinical Assays Of Lung Disease; Cystic Fibrosis; Differentiated Respiratory Epithelium; Induced Pluripotent Cells; Molecular Recognition; Small Molecules
From CIHR, NSERC and SSHRC funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998, including their latest published competition results.
A short, specific email works best. This draft uses one of their recent papers; replace the parts in brackets with your own details before sending.